These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37111726)

  • 21. Redox-Sensitive Hyaluronic Acid Polymer Prodrug Nanoparticles for Enhancing Intracellular Drug Self-Delivery and Targeted Cancer Therapy.
    Lu B; Xiao F; Wang Z; Wang B; Pan Z; Zhao W; Zhu Z; Zhang J
    ACS Biomater Sci Eng; 2020 Jul; 6(7):4106-4115. PubMed ID: 33463311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 23. Nanotherapy delivery of c-myc inhibitor targets Protumor Macrophages and preserves Antitumor Macrophages in Breast Cancer.
    Esser AK; Ross MH; Fontana F; Su X; Gabay A; Fox GC; Xu Y; Xiang J; Schmieder AH; Yang X; Cui G; Scott M; Achilefu S; Chauhan J; Fletcher S; Lanza GM; Weilbaecher KN
    Theranostics; 2020; 10(17):7510-7526. PubMed ID: 32685002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-CD206 antibody-conjugated Fe
    Zhou Y; Que KT; Tang HM; Zhang P; Fu QM; Liu ZJ
    Oncol Lett; 2020 Dec; 20(6):298. PubMed ID: 33101492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma.
    Kim KJ; Wen XY; Yang HK; Kim WH; Kang GH
    PLoS One; 2015; 10(12):e0144192. PubMed ID: 26714314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photoresponsive Block Copolymer Prodrug Nanoparticles as Delivery Vehicle for Single and Dual Anticancer Drugs.
    Biswas G; Jena BC; Maiti S; Samanta P; Mandal M; Dhara D
    ACS Omega; 2017 Oct; 2(10):6677-6690. PubMed ID: 30023528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Lymphoma Efficacy Comparison of Anti-Cd20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates.
    Lidický O; Janoušková O; Strohalm J; Alam M; Klener P; Etrych T
    Molecules; 2015 Nov; 20(11):19849-64. PubMed ID: 26556320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multifunctional Polymeric Prodrug with Simultaneous Conjugating Camptothecin and Doxorubicin for pH/Reduction Dual-Responsive Drug Delivery.
    Dong S; Sun Y; Liu J; Li L; He J; Zhang M; Ni P
    ACS Appl Mater Interfaces; 2019 Mar; 11(9):8740-8748. PubMed ID: 30693750
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leveraging Nanodrug Delivery System for Simultaneously Targeting Tumor Cells and M2 Tumor-Associated Macrophages for Efficient Colon Cancer Therapy.
    Zeng J; Sun Y; Sun S; Jiang M; Zhang D; Li W; Liu Z; Shang H; Guan X; Zhang W
    ACS Appl Mater Interfaces; 2022 Nov; 14(45):50475-50484. PubMed ID: 36327132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of density of tumor-associated macrophages using CD163 in histological grades of oral squamous cell carcinoma, an immunohistochemical study.
    Chaudhari N; Prakash N; Pradeep GL; Mahajan A; Lunawat S; Salunkhe V
    J Oral Maxillofac Pathol; 2020; 24(3):577. PubMed ID: 33967504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photo- and pH-Responsive Polycarbonate Block Copolymer Prodrug Nanomicelles for Controlled Release of Doxorubicin.
    Kalva N; Uthaman S; Augustine R; Jeon SH; Huh KM; Park IK; Kim I
    Macromol Biosci; 2020 Aug; 20(8):e2000118. PubMed ID: 32567108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodistribution and in vivo activities of tumor-associated macrophage-targeting nanoparticles incorporated with doxorubicin.
    Niu M; Naguib YW; Aldayel AM; Shi YC; Hursting SD; Hersh MA; Cui Z
    Mol Pharm; 2014 Dec; 11(12):4425-36. PubMed ID: 25314115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor microenvironment remodeling via targeted depletion of M2-like tumor-associated macrophages for cancer immunotherapy.
    Cao Y; Qiao B; Chen Q; Xie Z; Dou X; Xu L; Ran H; Zhang L; Wang Z
    Acta Biomater; 2023 Apr; 160():239-251. PubMed ID: 36774974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential role of tumor-associated macrophages and CD163/CD68 ratio in mycosis fungoides and Sézary syndrome in correlation with serum sCD163 and CCL22.
    El-Guindy DM; Elgarhy LH; Elkholy RA; Ali DA; Helal DS
    J Cutan Pathol; 2022 Mar; 49(3):261-273. PubMed ID: 34687561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody combinations for optimized staining of macrophages in human lung tumours.
    Frafjord A; Skarshaug R; Hammarström C; Stankovic B; Dorg LT; Aamodt H; Woldbaek PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Scand J Immunol; 2020 Jul; 92(1):e12889. PubMed ID: 32299134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH/ROS dual-responsive supramolecular polypeptide prodrug nanomedicine based on host-guest recognition for cancer therapy.
    Ding Y; Wang C; Ma Y; Zhu L; Lu B; Wang Y; Wang J; Chen T; Dong CM; Yao Y
    Acta Biomater; 2022 Apr; 143():381-391. PubMed ID: 35272024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Target delivery selective CSF-1R inhibitor to tumor-associated macrophages via erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy.
    Wang Y; Luan Z; Zhao C; Bai C; Yang K
    Eur J Pharm Sci; 2020 Jan; 142():105136. PubMed ID: 31704343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A unique anti-CD115 monoclonal antibody which inhibits osteolysis and skews human monocyte differentiation from M2-polarized macrophages toward dendritic cells.
    Haegel H; Thioudellet C; Hallet R; Geist M; Menguy T; Le Pogam F; Marchand JB; Toh ML; Duong V; Calcei A; Settelen N; Preville X; Hennequi M; Grellier B; Ancian P; Rissanen J; Clayette P; Guillen C; Rooke R; Bonnefoy JY
    MAbs; 2013; 5(5):736-47. PubMed ID: 23924795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
    Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
    Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.